(Total Views: 198)
Posted On: 07/12/2022 4:35:51 PM
Post# of 145184

$ATRA News Article - Atara Biotherapeutics Announces Completion of the ATA188 Phase 2 EMBOLD Study Interim Analysis in Patients with Progressive MS https://marketwirenews.com/news-releases/atar...18134.html


My Twitter: WhyteStocks